Free Trial
OTCMKTS:NRXGQ

NephroGenex (NRXGQ) Stock Price, News & Analysis

NephroGenex logo

About NephroGenex Stock (OTCMKTS:NRXGQ)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
2,000 shs
Average Volume
26,223 shs
Market Capitalization
$36,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

NephroGenex, Inc. is a pharmaceutical company. The Company is focused on the development of therapeutics to treat kidney disease. The Company has paused the clinical program of its product candidate, oral Pyridorin, for the treatment of diabetic nephropathy. The Company was primarily focused on the Phase III Pyridorin program, and other planned clinical and nonclinical studies and other work needed to submit Pyridorin for acute kidney injury (AKI), as well as the treatment of diabetic nephropathy in patients with Type II diabetes for regulatory approval in the United States and Europe. The Company has not generated any revenues.

Receive NRXGQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NephroGenex and its competitors with MarketBeat's FREE daily newsletter.

NRXGQ Stock News Headlines

Habib Kairouz's Net Worth
Elicera Therapeutics AB (ELIC)
Think NVDA’s run was epic? You ain’t seen nothin’ yet
Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?
LL Lucky Games publ AB (LADYLU)
Xinjiang Daqo New Energy Co Ltd (688303)
Tsukuba Bank Ltd (8338)
PEXA Group Ltd (PXA)
Kosei Securities Co Ltd (8617)
See More Headlines

NRXGQ Stock Analysis - Frequently Asked Questions

Shares of NRXGQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Electronic Computer Manufacturing
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:NRXGQ
Previous Symbol
NASDAQ:NRX
Fax
N/A
Employees
1,700
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$36,000.00
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (OTCMKTS:NRXGQ) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners